Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.53, $0.07 better than the analyst estimate of $0.46. Revenue for the quarter came in at $721.7 million versus the consensus estimate of $729.92 million.

GUIDANCE:

Bruker sees FY2024 EPS of $2.79-$2.84, versus the consensus of $2.71. Bruker sees FY2024 revenue of $3.29-3.35 billion, versus the consensus of $3.28 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.